Should Lactobacillus sporogenes and Bacillus coagulans have a future?

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Probiotics are gaining increasing scientific and commercial interest as functional foods. Their success has led to the development and marketing of a broad range of products based on probiotics. In this context, resolution of the taxonomy of microbial species remains a key point, since different species belonging to the same genus may have different beneficial properties. Lactobacillus sporogenes, which should be correctly classified as Bacillus coagulans, represents the archetypal misidentified probiotic and its inclusion among probiotics has often been a matter of debate. Since this bacterium shows characteristics of both genera Lactobacillus and Bacillus, its taxonomic position between the families Lactobacillaceae and Bacillaceae has often been discussed. This review summarizes the salient probiotic features of L. sporogenes/B. coagulans by examining currently available information. Although the use of L sporogenes spores as a probiotic has increased in recent years, clinical evidence of its benefits are limited to only a few studies involving small patient populations.

Original languageEnglish
Pages (from-to)371-377
Number of pages7
JournalJournal of Chemotherapy
Volume21
Issue number4
Publication statusPublished - Aug 2009

Fingerprint

Probiotics
Lactobacillaceae
Bacillaceae
Functional Food
Lactobacillus
Marketing
Spores
Bacillus
Bacillus coagulans
Bacteria
Population

Keywords

  • Bacillus coagulans
  • Bacterial taxonomy
  • Lacobacillus sporogenes
  • Probiotics

ASJC Scopus subject areas

  • Infectious Diseases
  • Oncology
  • Pharmacology (medical)
  • Pharmacology

Cite this

Should Lactobacillus sporogenes and Bacillus coagulans have a future? / Drago, L.; De Vecchi, E.

In: Journal of Chemotherapy, Vol. 21, No. 4, 08.2009, p. 371-377.

Research output: Contribution to journalArticle

@article{5b2b5fcac06147cca2837ed14ef3c9e8,
title = "Should Lactobacillus sporogenes and Bacillus coagulans have a future?",
abstract = "Probiotics are gaining increasing scientific and commercial interest as functional foods. Their success has led to the development and marketing of a broad range of products based on probiotics. In this context, resolution of the taxonomy of microbial species remains a key point, since different species belonging to the same genus may have different beneficial properties. Lactobacillus sporogenes, which should be correctly classified as Bacillus coagulans, represents the archetypal misidentified probiotic and its inclusion among probiotics has often been a matter of debate. Since this bacterium shows characteristics of both genera Lactobacillus and Bacillus, its taxonomic position between the families Lactobacillaceae and Bacillaceae has often been discussed. This review summarizes the salient probiotic features of L. sporogenes/B. coagulans by examining currently available information. Although the use of L sporogenes spores as a probiotic has increased in recent years, clinical evidence of its benefits are limited to only a few studies involving small patient populations.",
keywords = "Bacillus coagulans, Bacterial taxonomy, Lacobacillus sporogenes, Probiotics",
author = "L. Drago and {De Vecchi}, E.",
year = "2009",
month = "8",
language = "English",
volume = "21",
pages = "371--377",
journal = "Journal of Chemotherapy",
issn = "1120-009X",
publisher = "Maney Publishing",
number = "4",

}

TY - JOUR

T1 - Should Lactobacillus sporogenes and Bacillus coagulans have a future?

AU - Drago, L.

AU - De Vecchi, E.

PY - 2009/8

Y1 - 2009/8

N2 - Probiotics are gaining increasing scientific and commercial interest as functional foods. Their success has led to the development and marketing of a broad range of products based on probiotics. In this context, resolution of the taxonomy of microbial species remains a key point, since different species belonging to the same genus may have different beneficial properties. Lactobacillus sporogenes, which should be correctly classified as Bacillus coagulans, represents the archetypal misidentified probiotic and its inclusion among probiotics has often been a matter of debate. Since this bacterium shows characteristics of both genera Lactobacillus and Bacillus, its taxonomic position between the families Lactobacillaceae and Bacillaceae has often been discussed. This review summarizes the salient probiotic features of L. sporogenes/B. coagulans by examining currently available information. Although the use of L sporogenes spores as a probiotic has increased in recent years, clinical evidence of its benefits are limited to only a few studies involving small patient populations.

AB - Probiotics are gaining increasing scientific and commercial interest as functional foods. Their success has led to the development and marketing of a broad range of products based on probiotics. In this context, resolution of the taxonomy of microbial species remains a key point, since different species belonging to the same genus may have different beneficial properties. Lactobacillus sporogenes, which should be correctly classified as Bacillus coagulans, represents the archetypal misidentified probiotic and its inclusion among probiotics has often been a matter of debate. Since this bacterium shows characteristics of both genera Lactobacillus and Bacillus, its taxonomic position between the families Lactobacillaceae and Bacillaceae has often been discussed. This review summarizes the salient probiotic features of L. sporogenes/B. coagulans by examining currently available information. Although the use of L sporogenes spores as a probiotic has increased in recent years, clinical evidence of its benefits are limited to only a few studies involving small patient populations.

KW - Bacillus coagulans

KW - Bacterial taxonomy

KW - Lacobacillus sporogenes

KW - Probiotics

UR - http://www.scopus.com/inward/record.url?scp=70349226780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349226780&partnerID=8YFLogxK

M3 - Article

VL - 21

SP - 371

EP - 377

JO - Journal of Chemotherapy

JF - Journal of Chemotherapy

SN - 1120-009X

IS - 4

ER -